مکتبة رقمیه للعلوم الطبيه
Your cart is empty.
  • Cart
  • Lists
    Your lists Log in to create your own lists
  • Log in to your account
  • Your cookies
  • Search history
  • Advanced search
  • Authority search
  • Tag cloud
  • Library

Log in to your account

  1. Home
  2. Details for: Yes1 signaling mediates the resistance to Trastuzumab/Lap atinib in breast cancer.
Normal view MARC view ISBD view

Yes1 signaling mediates the resistance to Trastuzumab/Lap atinib in breast cancer. [electronic resource]

By:
  • Takeda, Tatsuaki
Contributor(s):
  • Yamamoto, Hiromasa
  • Kanzaki, Hirotaka
  • Suzawa, Ken
  • Yoshioka, Takahiro
  • Tomida, Shuta
  • Cui, Xiaojiang
  • Murali, Ramachandran
  • Namba, Kei
  • Sato, Hiroki
  • Torigoe, Hidejiro
  • Watanabe, Mototsugu
  • Shien, Kazuhiko
  • Soh, Junichi
  • Asano, Hiroaki
  • Tsukuda, Kazunori
  • Kitamura, Yoshihisa
  • Miyoshi, Shinichiro
  • Sendo, Toshiaki
  • Toyooka, Shinichi
Producer: 20170828Description: e0171356 p. digitalISSN:
  • 1932-6203
Subject(s):
  • Apoptosis -- drug effects
  • Blotting, Western
  • Breast Neoplasms -- metabolism
  • Cell Cycle -- drug effects
  • Cell Line, Tumor
  • Computational Biology
  • Drug Resistance, Neoplasm -- genetics
  • Female
  • Humans
  • Lapatinib
  • Proto-Oncogene Mas
  • Proto-Oncogene Proteins c-yes -- genetics
  • Quinazolines -- pharmacology
  • RNA, Small Interfering -- genetics
  • Receptor, ErbB-2 -- metabolism
  • Reverse Transcriptase Polymerase Chain Reaction
  • Signal Transduction -- drug effects
  • Trastuzumab -- pharmacology
Online resources:
  • Available from publisher's website
In: PloS one vol. 12
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Cancel rating. Average rating: 0.0 (0 votes)
  • Holdings ( 0 )
  • Title notes ( 1 )
  • Comments ( 0 )
No physical items for this record

Publication Type: Journal Article

There are no comments on this title.

Log in to your account to post a comment.

Yes1 signaling mediates the resistance to Trastuzumab/Lap atinib in breast cancer.

APA

Takeda T., Yamamoto H., Kanzaki H., Suzawa K., Yoshioka T., Tomida S., Cui X., Murali R., Namba K., Sato H., Torigoe H., Watanabe M., Shien K., Soh J., Asano H., Tsukuda K., Kitamura Y., Miyoshi S., Sendo T. & Toyooka S. (20170828). Yes1 signaling mediates the resistance to Trastuzumab/Lap atinib in breast cancer. : PloS one.

Chicago

Takeda Tatsuaki, Yamamoto Hiromasa, Kanzaki Hirotaka, Suzawa Ken, Yoshioka Takahiro, Tomida Shuta, Cui Xiaojiang, Murali Ramachandran, Namba Kei, Sato Hiroki, Torigoe Hidejiro, Watanabe Mototsugu, Shien Kazuhiko, Soh Junichi, Asano Hiroaki, Tsukuda Kazunori, Kitamura Yoshihisa, Miyoshi Shinichiro, Sendo Toshiaki and Toyooka Shinichi. 20170828. Yes1 signaling mediates the resistance to Trastuzumab/Lap atinib in breast cancer. : PloS one.

Harvard

Takeda T., Yamamoto H., Kanzaki H., Suzawa K., Yoshioka T., Tomida S., Cui X., Murali R., Namba K., Sato H., Torigoe H., Watanabe M., Shien K., Soh J., Asano H., Tsukuda K., Kitamura Y., Miyoshi S., Sendo T. and Toyooka S. (20170828). Yes1 signaling mediates the resistance to Trastuzumab/Lap atinib in breast cancer. : PloS one.

MLA

Takeda Tatsuaki, Yamamoto Hiromasa, Kanzaki Hirotaka, Suzawa Ken, Yoshioka Takahiro, Tomida Shuta, Cui Xiaojiang, Murali Ramachandran, Namba Kei, Sato Hiroki, Torigoe Hidejiro, Watanabe Mototsugu, Shien Kazuhiko, Soh Junichi, Asano Hiroaki, Tsukuda Kazunori, Kitamura Yoshihisa, Miyoshi Shinichiro, Sendo Toshiaki and Toyooka Shinichi. Yes1 signaling mediates the resistance to Trastuzumab/Lap atinib in breast cancer. : PloS one. 20170828.

  • Print
  • Cite
  • Add to your cart (remove)
  • Save record
    BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
  • More searches
    Search for this title in:
    Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)

Exporting to Dublin Core...

Visit web site